NAD+ IV Therapy for Depression and Anxiety: The Evidence

If you search for help with depression or anxiety, you'll eventually find a wellness clinic offering an intravenous NAD+ drip as a "natural reset" for your mood — sometimes pitched as a way to "rebalance brain chemistry" or "restore mental clarity" without medication. The marketing is confident, the testimonials are glowing, and the mechanism, on the surface, sounds scientific: your brain runs on cellular energy, NAD+ powers that energy, so topping it up should lift your mood.

Mental health is exactly the area where that kind of confident, mechanism-flavored pitch deserves the most scrutiny — because depression and anxiety are serious, sometimes dangerous conditions, and because people in distress are especially vulnerable to spending money on hope. So this page lays out, honestly, why NAD+ is even proposed for mood, what the human evidence actually shows (very little, and what exists is largely negative), and why an IV drip should not be mistaken for treatment.

If you are in crisis or having thoughts of harming yourself, please reach out now — in the US, call or text 988 (the Suicide & Crisis Lifeline). This article is about evaluating a marketed therapy, not a substitute for care.

Why NAD+ is even proposed for mood

The rationale isn't pulled from thin air. NAD+ (nicotinamide adenine dinucleotide) is a coenzyme in every cell that carries electrons through the reactions turning food into usable energy, and it also fuels DNA-repair enzymes and the sirtuins. Because it sits at the center of energy metabolism, low NAD+ availability can ripple outward into mitochondrial and metabolic dysfunction ¹, and NAD+ tends to fall with age and metabolic stress in human tissue ².

What gives the mood pitch a sheen of credibility is a genuine and growing line of research linking mitochondrial dysfunction to depression. People with major and bipolar depression show measurable alterations in mitochondrial DNA — oxidation, methylation, and copy-number changes ³ — and patients in acute bipolar episodes show reduced mitochondrial respiratory capacity, leading some researchers to frame mood disorders partly as state-dependent "mitochondrial" conditions ⁴. There's even a small human signal tying NAD+ metabolism specifically to mood: a 2025 preliminary study found that serum levels of an NAD+ metabolite (nudifloramide) shifted in association with response to antidepressant treatment ⁵.

So the chain the clinics draw — low cellular energy → mitochondrial dysfunction → depression → fix it by raising NAD+ — has real scientific touchpoints. The problem is that every one of those touchpoints is a correlation or a mechanism, and none of them is evidence that giving someone NAD+ actually treats their depression or anxiety.

What the human evidence actually shows

Here is the honest core of this page: there is no rigorous randomized trial showing that NAD+ — by IV or any other route — improves depression or anxiety. And the closest controlled human data we have is not encouraging.

The most relevant trial gave oral nicotinamide riboside (NR), a well-studied NAD+ precursor, at 2,000 mg/day in a double-blind, placebo-controlled study, and it measured anxiety and depression symptoms among its outcomes ⁶. The result: no significant between-group difference in symptoms of anxiety (p = 0.84) or depression (p = 0.20) versus placebo ⁶. Participants did report some within-group improvement while taking NR, but that uncontrolled comparison is exactly the kind of signal that placebo and natural fluctuation produce — which is why the placebo-controlled comparison is the one that counts, and it was null. (That trial was in long-COVID patients rather than primary depression, so it isn't the final word — but it is the best controlled look we have at an NAD+ booster and mood, and it found no mood benefit.)

For the IV route specifically — the one the mood clinics actually sell — the evidence is thinner still. The only published human IV NAD+ study ever conducted measured the metabolome during a 6-hour infusion and found free NAD+ wasn't even readily detectable in blood for hours; it tested no psychiatric outcome at all ⁷. There is no IV NAD+ trial for depression, anxiety, or any mental-health condition. We cover that route's evidence and cost in detail in our NAD+ IV therapy evidence guide.

This fits a pattern that runs through the entire NAD+ field: raising the NAD+ biomarker reliably is not the same as improving how people feel or function. When NR raised NAD+ in older adults with mild cognitive impairment, cognition was unchanged ⁸; a systematic review and meta-analysis of NAD+ precursors on metabolic-syndrome parameters found benefits limited and inconsistent despite reliably raised NAD+ ⁹. If the biomarker moves but the outcomes don't in the conditions that have been studied, an IV drip marketed for mood — with no mood trials behind it — cannot honestly claim to work. We unpack this "biomarker is not benefit" problem in our pillar guide to NAD+ therapy evidence and in does NAD+ actually boost energy.

Why the testimonials are weak evidence

Mood is one of the most placebo-responsive outcomes in all of medicine. Depression and anxiety fluctuate naturally, often improve with time, attention, and structure, and respond strongly to expectation. An expensive, ritualized, hours-long infusion delivered by attentive staff in a calming clinic is practically engineered to produce a felt lift — regardless of what's in the bag. That's not a knock on the people who feel better; it's the entire reason placebo-controlled trials exist, and it's why a glowing testimonial can't substitute for a controlled comparison. The one controlled comparison we have found no benefit over placebo ⁶.

This is the same caution we raise about NAD+ drips marketed for addiction recovery, another high-stakes psychiatric arena where the pitch outruns the proof.

What actually has evidence — and don't trade it away

This is the most important section. Depression and anxiety have treatments backed by large, controlled trials and decades of clinical experience: psychotherapy (especially cognitive behavioral therapy), antidepressant and anti-anxiety medications, and, for treatment-resistant cases, options like newer rapid-acting agents and brain-stimulation therapies. These work, they're studied, and most are inexpensive or covered by insurance.

The real danger of the NAD+-for-mood pitch is opportunity cost: someone in genuine distress spends hundreds or thousands of dollars on an unproven drip instead of seeking care that is known to help — or worse, delays treatment for a worsening condition. At best, NAD+ IV therapy is an expensive, unproven add-on with no controlled evidence for mood. It is not a treatment for depression or anxiety, and any clinic implying otherwise is overselling.

If you're drawn to NAD+, understand the whole picture first and talk to a mental-health professional about your symptoms. Start with our NAD+ therapy evidence pillar, see the route reality and pricing in our NAD+ IV therapy evidence guide, review the side effects before any infusion, and see how products and providers compare on our NAD+ rankings hub. For your mood itself, the evidence-based first step is a clinician — not a drip.